Robeauté

Robeaute operates at the intersection of robotics, artificial intelligence, and medical sciences, developing a groundbreaking microrobotic platform designed for neurosurgical interventions. This innovative device allows for high-precision 3D, non-linear movements and live data collection, making it a valuable tool for neurosurgeons. The microrobot is modular, featuring a standard carrier with multiple extensions that can adapt to various medical needs, such as implanting electrodes, delivering molecules, sampling tissue, or collecting live data through sensors. Despite its potential, the product has not yet received FDA or EMA clearance and is not available for commercial sale. Robeaute's primary clients are medical professionals and institutions specializing in neurosurgery. The company operates in the medical technology market, focusing on enhancing surgical precision and patient outcomes. Its business model revolves around developing and eventually commercializing advanced medical devices. Revenue will be generated through the sale of these devices and potentially through partnerships with medical institutions and research organizations.

Keywords: microrobotics, neurosurgery, precision, 3D movements, real-time data, modular device, AI integration, medical technology, surgical innovation, non-invasive.